Performance of first pacemaker to use smart device app for remote monitoring
| Autor: | Antonio Porfilio, Martin Emert, Keith Holloman, Suneet Mittal, Abdul R. Maher, John Schoenhard, Mintu P. Turakhia, Naushad A. Shaik, Hanscy Seide, Niraj Varma, Ana C. Natera, Paul R. Roberts, Sherry L. Di Jorio, Giuseppe Augello, Baerbel Maus, Nilam Patel, Khaldoun G. Tarakji, Ashish Patwala, Samuel F. Sears, Giulio Molon, Steven L. Zweibel, Josh R. Silverstein, Amir Zaidi, James Allred |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Telemedicine Smart devices business.industry medicine.medical_treatment Smart device Cardiac resynchronization therapy Patient engagement Device type law.invention Pacemaker Bluetooth Clinical Remote monitoring law Emergency medicine Devices medicine business Digital health |
| Zdroj: | Heart Rhythm O2 |
| ISSN: | 2666-5018 |
| Popis: | Background High adherence to remote monitoring (RM) in pacemaker (PM) patients improves outcomes; however, adherence remains suboptimal. Bluetooth low-energy (BLE) technology in newer-generation PMs enables communication directly with patient-owned smart devices using an app without a bedside console. Objective To evaluate the success rate of scheduled RM transmissions using the app compared to other RM methods. Methods The BlueSync Field Evaluation was a prospective, international cohort evaluation, measuring the success rate of scheduled RM transmissions using a BLE PM or cardiac resynchronization therapy PM coupled with the MyCareLink Heart app. App transmission success was compared to 3 historical “control” groups from the Medtronic de-identified CareLink database: (1) PM patients with manual communication using a wand with a bedside console (PM manual transmission), (2) PM patients with wireless automatic communication with the bedside console (PM wireless); (3) defibrillator patients with similar automatic communication (defibrillator wireless). Results Among 245 patients enrolled (age 64.8±15.6 years, 58.4% men), 953 transmissions were scheduled through 12 months, of which 902 (94.6%) were successfully completed. In comparison, transmission success rates were 56.3% for PM manual transmission patients, 77.0% for PM wireless patients, and 87.1% for defibrillator wireless patients. Transmission success with the app was superior across matched cohorts based on age, sex, and device type (single vs dual vs triple chamber). Conclusion The success rate of scheduled RM transmissions was higher among patients using the smart device app compared to patients using traditional RM using bedside consoles. This novel technology may improve patient engagement and adherence to RM. Graphical abstract |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|